Sign up to save your podcasts
Or
Share Introducing Novel Agents Into the Armamentarium for Triple-Negative Breast Cancer
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Introducing Novel Agents Into the Armamentarium for Triple-Negative Breast Cancer
CME credits: 1.00
Valid until: 30-04-2024
Claim your CME credit at https://reachmd.com/programs/cme/introducing-novel-agents-into-the-armamentarium-for-triple-negative-breast-cancer/15869/
Watch this educational activity to learn about the integration of novel agents into the treatment algorithm for patients with triple-negative breast cancer (TNBC) and current guideline-recommended strategies for the treatment and management of treatment-related adverse events in TNBC.
=
View all episodes
By ReachMD
4.3
33 ratings
CME credits: 1.00
Valid until: 30-04-2024
Claim your CME credit at https://reachmd.com/programs/cme/introducing-novel-agents-into-the-armamentarium-for-triple-negative-breast-cancer/15869/
Watch this educational activity to learn about the integration of novel agents into the treatment algorithm for patients with triple-negative breast cancer (TNBC) and current guideline-recommended strategies for the treatment and management of treatment-related adverse events in TNBC.
=